Compumedics Ltd - Asset Resilience Ratio

Latest as of June 2022: 16.97%

Compumedics Ltd (CMP) has an Asset Resilience Ratio of 16.97% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Compumedics Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

AU$7.08 Million

≈ $5.01 Million USD Cash + Short-term Investments

Total Assets

AU$41.71 Million

≈ $29.51 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2022)

This chart shows how Compumedics Ltd's Asset Resilience Ratio has changed over time. See net assets of Compumedics Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Compumedics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Compumedics Ltd (CMP) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$7.08 Million	16.97%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$7.08 Million	16.97%

Asset Resilience Insights

Good Liquidity Position: Compumedics Ltd maintains a healthy 16.97% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Compumedics Ltd Industry Peers by Asset Resilience Ratio

Compare Compumedics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Vitrolife AB ST:VITR	Medical Devices	7.27%
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	Medical Devices	19.31%
Tellgen Corp SHE:300642	Medical Devices	8.60%
Lumos Diagnostics Holdings Ltd AU:LDX	Medical Devices	9.40%
T&R Biofab Co. Ltd KQ:246710	Medical Devices	0.12%
Ok Biotech Co Ltd TW:4155	Medical Devices	0.32%
Promimic AB ST:PRO	Medical Devices	8.62%
Memphasys Ltd AU:MEM	Medical Devices	0.00%

Annual Asset Resilience Ratio for Compumedics Ltd (2016–2022)

The table below shows the annual Asset Resilience Ratio data for Compumedics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-06-30	16.97%	AU$7.08 Million ≈ $5.01 Million	AU$41.71 Million ≈ $29.51 Million	+5.08pp
2019-06-30	11.90%	AU$4.60 Million ≈ $3.25 Million	AU$38.66 Million ≈ $27.36 Million	+0.62pp
2018-06-30	11.27%	AU$3.91 Million ≈ $2.76 Million	AU$34.65 Million ≈ $24.52 Million	-2.76pp
2017-06-30	14.03%	AU$4.10 Million ≈ $2.90 Million	AU$29.23 Million ≈ $20.68 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$26.12 Million ≈ $18.48 Million	--

pp = percentage points

About Compumedics Ltd

AU:CMP Australia Medical Devices

Market Cap

$41.70 Million

AU$58.93 Million AUD

Market Cap Rank

#22544 Global

#842 in Australia

Share Price

AU$0.30

Change (1 day)

+3.51%

52-Week Range

AU$0.25 - AU$0.45

All Time High

AU$0.90